LOS ANGELES, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)KECK MEDICAL CENTER OF USC, founded in 2020, is a large national nonprofit in the Health Care sector that reported $2.2B in total revenue in fiscal year 2023. Revenue grew 11% year-over-year, indicating healthy expansion. Expenses of $2.1B left a modest 4% surplus.
ORGANIZATION'S PRIMARY ACTIVITY AND PROGRAM SERVICE ACCOMPLISHMENTS KECK MEDICAL CENTER OF USC (THE ORGANIZATION) WAS ORGANIZED ON JUNE 24, 2020 AS A CALIFORNIA NONPROFIT CORPORATION FOR EXCLUSIVELY CHARITABLE, SCIENTIFIC, AND EDUCATIONAL PURPOSES WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE INCLUDING; TO ESTABLISH, EQUIP, MAINTAIN, AND OPERATE ONE OR MORE NONPROFIT HOSPITALS, INCLUDING KECK HOSPITAL OF USC AND USC NORRIS CANCER HOSPITAL, AS PART OF THE INTEGRATED HEALTH CARE SYSTEM OF THE UNIVERSITY OF SOUTHERN CALIFORNIA, KECK MEDICINE OF USC ("KECK MEDICINE"); TO COORDINATE THE ACTIVITIES OF THE ORGANIZATION WITH OTHER ACTIVITIES OF KECK MEDICINE IN A MANNER THAT ENHANCES THE ACCESSIBILITY, QUALITY AND COST EFFECTIVENESS OF HEALTH CARE SERVICES RELATED TO THE COMMUNITIES SERVED BY THE ORGANIZATION, PROVIDES ASSOCIATED SERVICES INCLUDING, BUT NOT LIMITED TO, OUTPATIENT CARE AND EMERGENCY CARE, TO ALL PERSONS WITHOUT REGARD TO SEX, RACE, AGE, RELIGION, CREED, COLOR OR NATIONAL ORIGIN, SEXUAL ORIENTATION, OR PHYSICAL OR MENTAL DISABILITY, AND SUPPORTS THE EDUCATIONAL AND RESEARCH MISSIONS OF THE KECK SCHOOL OF MEDICINE OF THE UNIVERSITY OF SOUTHERN CALIFORNIA; TO PARTICIPATE IN ACTIVITIES DESIGNED AND CARRIED ON TO PROVIDE AND IMPROVE THE GENERAL PUBLIC HEALTH AND HEALTH OF PATIENTS SERVED BY KECK MEDICINE; AND IN FURTHERANCE OF THE PURPOSE, MISSION AND ACTIVITIES OF KECK MEDICINE, TO PROVIDE OTHER FORMS OF AID AND ASSISTANCE TO, FOR THE BENEFIT OF, OR IN CONNECTION WITH THE NONPROFIT COMPONENTS OF KECK MEDICINE. KECK IS A TERTIARY, QUATERNARY CARE HOSPITAL THAT PROVIDES CARE TO THE MOST ACUTELY ILL PATIENTS. ITS SPECIALTIES INCLUDE HEAD AND NECK ONCOLOGY, INPATIENT REHABILITATION, AND KIDNEY TRANSPLANT SERVICES, AMONG OTHERS. ITS INTERNATIONALLY RENOWNED PHYSICIANS CARE FOR PATIENTS, AND TEACH AND CONDUCT RESEARCH AT THE KECK SCHOOL OF MEDICINE OF USC, THE REGION'S FIRST MEDICAL SCHOOL. KECK PROVIDES INNOVATIVE CARE FOR COMPLEX MEDICAL AND SURGICAL ISSUES. HIGHLY TRAINED SPECIALISTS IN EACH AREA PROVIDE EVERY PATIENT WITH AN INDIVIDUALIZED, YET EXTENSIVE CARE PLAN. HUNDREDS OF CLINICAL TRIALS ARE CURRENTLY TAKING PLACE AT KECK AND ITS AFFILIATED RESEARCH INSTITUTIONS, GIVING PARTICIPANTS ACCESS TO NOVEL AND PROMISING THERAPIES THAT GENERALLY ARE NOT AVAILABLE ELSEWHERE. NORRIS IS ONE OF THE NATION'S FIFTY-ONE COMPREHENSIVE CANCER CENTERS, DEDICATED TO THE RESEARCH AND DEVELOPMENT OF APPROACHES TO THE PREVENTION, DIAGNOSIS, AND TREATMENT OF CANCER. IT IS ONE OF THE EIGHT ORIGINAL COMPREHENSIVE CANCER CENTERS DESIGNATED BY THE NATIONAL CANCER INSTITUTE AND HAS A MISSION TO TRANSLATE SCIENTIFIC DISCOVERIES INTO INNOVATIVE THERAPIES FOR ITS PATIENTS. NORRIS'S RESEARCH BREAKTHROUGHS HAVE LED THE WAY TO A GREATER UNDERSTANDING OF THE UNDERLYING CAUSES OF CANCER AND NEW METHODS OF PREVENTION, DETECTION AND TREATMENT. NORRIS FOCUSES ON THIRTEEN KEY AREAS OF CANCER TREATMENT: BREAST CANCER, GASTROINTESTINAL CANCER, GENETIC COUNSELING, GYNECOLOGICAL CANCERS, HEAD AND NECK CANCERS, HEMATOLOGY, LUNG CANCER, MELANOMA, NEURO-ONCOLOGY, RADIATION ONCOLOGY, SARCOMA, SKIN CANCER AND UROLOGIC ONCOLOGY. USING A MULTIDISCIPLINARY TEAM APPROACH, THE MORE THAN 250 DEDICATED PHYSICIANS AND SCIENTISTS OF NORRIS TREAT AND PREVENT CANCER BY DEVELOPING NEW THERAPIES, ENHANCING EXISTING PROTOCOLS AND PROVIDING PERSONALIZED, PRECISION CARE THAT IS THE MOST ADVANCED AVAILABLE. AS AN INTEGRAL PART OF A UNIVERSITY-BASED MEDICAL CENTER, NORRIS OFFERS ACCESS TO HUNDREDS OF INNOVATIVE CLINICAL TRIALS AND EXTENSIVE PATIENT EDUCATION, EMPOWERING PATIENTS TO TAKE AN ACTIVE ROLE IN THEIR HEALTH CARE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,162,289,507 | $1,943,542,115 | +0.1% |
| Expenses | $2,081,076,404 | $1,750,438,391 | +0.2% |
| Net Income | $81,213,103 | $193,103,724 | -0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| VAUGHN STARNES MD | Director | 2.0 |
Director
|
$0 | $79,063 | $3,889,780 |
| ROD HANNERS | Director | 2.0 |
Director
|
$0 | $59,481 | $2,347,640 |
| CAROLYN MELTZER MD | Director | 2.0 |
Director
|
$0 | $50,764 | $1,659,286 |
| DAVID PENG MD MPH | Director | 50.0 |
Director
|
$0 | $85,141 | $1,568,130 |
| ERIK BRINK | DIRECTOR (AS OF 11/1/23) | 2.0 |
Director
|
$0 | $146,400 | $1,448,929 |
| MARTY SARGEANT | President/CEO/Director/Chair | 2.0 |
Officer
Director
|
$0 | $76,922 | $1,286,629 |
| CARYN LERMAN PHD | Director | 2.0 |
Director
|
$0 | $71,940 | $1,164,680 |
| CHRIS ALLEN | CFO/TREASURER | 33.0 |
Officer
|
$0 | $64,204 | $964,890 |
| STEVEN SIEGEL MD PHD | Director | 50.0 |
Director
|
$0 | $81,067 | $934,472 |
| MARK TODD PHD | Director | 50.0 |
Director
|
$0 | $194,878 | $805,161 |
| TAMARA CAPRETTA MPH RN | Director | 2.0 |
Director
|
$0 | $51,524 | $805,074 |
| STEPHANIE HALL MD | Director/CMO - KMC | 50.0 |
Director
|
$0 | $51,601 | $803,759 |
| HOLLY MUIR MD | Director | 2.0 |
Director
|
$0 | $69,017 | $777,745 |
| KRIST AZIZIAN | Chief Pharmacy Officer | 25.0 |
|
$0 | $85,284 | $735,449 |
| FRED WEAVER | Director | 0.0 |
Director
|
$0 | $54,604 | $690,579 |
| DIANA VO | RN/Operating Room | 2.0 |
Highest
|
$0 | $63,518 | $605,297 |
| ANNETTE SY DNP MSN RN | Director/CNO | 50.0 |
Director
|
$0 | $68,453 | $599,519 |
| JON REUTER | COO Keck Hospital | 50.0 |
Key Emp
|
$0 | $61,551 | $576,558 |
| DONALD LONGJOHN | DIRECTOR | 2.0 |
Director
|
$0 | $77,672 | $537,348 |
| JEANNINE TAYLOR | Secretary | 50.0 |
Officer
|
$0 | $123,494 | $519,905 |
| BRYNDA COLLINS | Chief Surgical & Procedural Op | 50.0 |
Highest
|
$0 | $48,671 | $495,699 |
| JOI TORRENCE-HILL | COO Norris | 50.0 |
Key Emp
|
$0 | $68,409 | $464,731 |
| CEONNE HOUSTON RAASIKH | CNO - KMC | 50.0 |
Highest
|
$0 | $57,227 | $454,390 |
| Christopher Teano | RN - CLINICAL (UNION) | 2.0 |
Highest
|
$0 | $80,887 | $443,932 |
| DARRYL TAKIGUCHI | RN - CLINICAL (UNION) | 2.0 |
Highest
|
$0 | $41,766 | $425,167 |
| ERIC STRUCKO | SEE SCHEDULE O FOR TITLE | 50.0 |
|
$0 | $34,838 | $342,410 |
| DEBORAH L MCCOY | CNO (as of 10/09/23) | 2.0 |
Key Emp
|
$0 | $13,908 | $341,782 |
| MICHAEL GALLAGHER | Director | 2.0 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $2,162,289,507 | $2,081,076,404 | $1,772,106,837 | $81,213,103 |
| 2023 | $1,943,542,115 | $1,750,438,391 | $1,661,060,577 | $193,103,724 |
| 2022 | $1,862,402,135 | $1,859,404,750 | $1,320,222,124 | $2,997,385 |
| 2021 | $861,650,395 | $850,211,644 | $1,126,857,717 | $11,438,751 |
Compare KECK MEDICAL CENTER OF USC with other nonprofits in California and across the country.